17 This notwithstanding, also our meta‐analysis disclosed a positive trend regarding the risk of decompensation (aHR .49, .19–1.26), though with high heterogeneity, and we feel that such a relevant issue merits to be assessed in dedicated, prospective studies based on patient‐level data.
← all excerpts
Effects of glucagon-like PEPTIDE-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: A systematic review and META-analysis.
1
—
—